One hundred eighty patients with variceal bleeding and treated by long-term sclerotherapy were randomized into a prospective randomized controlled clinical trial to assess the efficacy of sucralfate in reducing the frequency of rebleeding from esophageal ulceration prior to variceal obliteration. Ov
Results of nonshunting operation and injection sclerotherapy for esophageal varices
โ Scribed by Kawasaki, Seiji ;Sanjo, Kensho ;Idezuki, Yasuo
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 259 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Survival after prophylactic sclerotherapy was assessed in a single-center study involving 99 cirrhotic (41 alcoholic) patients enrolled over 8-yr. The wedged hepatic vein pressure gradient was measured; those with pressure 3 12 mm Hg were randomized to receive sclerotherapy or no treatment. The rest
Long-term follow-up (median: 37 months; range: 19 to 68) of the 116 patients (66 sclerotherapy, 60 control group) entered into a controlled trial of endoscopic variceal sclerotherapy has shown a total of 18 deaths in the sclerotherapy group, including five from variceal bleeding compared with 32 dea
AND SHOU-DONG LEE'" Endoscopic variceal injection sclerotherapy (EVS) has been well accepted as the procedure of choice for the treatment. of acute esophageal variceal bleeding and serves as the standard for comparison of new ther-